InvestorsHub Logo
Followers 15
Posts 1724
Boards Moderated 0
Alias Born 08/12/2007

Re: TechKim post# 731

Wednesday, 09/12/2018 8:02:25 PM

Wednesday, September 12, 2018 8:02:25 PM

Post# of 796

I agree about this stock. Makes no sense. Even the way the market reacted after approval.




The first sale of Azedra triggers an $8M milestone payment to former Molecular Insight Pharma holders. This in turn compounded the strategy to "sell the news" by certain investors, before the company tapped the market again.

Ascribe greater value to things you don't have to worry about